Stay updated on Niagen™ Supplementation Clinical Trial

Sign up to get notified when there's something new on the Niagen™ Supplementation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niagen™ Supplementation Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T12:12:38.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T12:59:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The 403 Forbidden page’s footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:15:22.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Access to the study page now displays a 403 Forbidden error instead of the study details. The page content is replaced by a standard error and site footer, indicating the resource is blocked.
    Difference
    18%
    Check dated 2026-09-20T20:32:18.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page revision stamp updated from v3.6.5 to v3.6.6, indicating a small release update to the page or system. There are no changes to the study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-08-30T08:33:31.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Replaced the error placeholder with the full study record for Niagen study (NCT02712593). The new content includes the official title, study design (randomized, double-blind, placebo-controlled), arms (Niagen 100/300/1000 and placebo), primary/secondary outcomes, eligibility criteria, and sponsor/investigators, plus location details.
    Difference
    47%
    Check dated 2026-08-16T02:07:35.000Z thumbnail image

Stay in the know with updates to Niagen™ Supplementation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niagen™ Supplementation Clinical Trial page.